# RIVASTIGMINE TARTRATE
> **ANDA203148** · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2014-08-22
## Drug
- **FDA Application Number:** ANDA203148
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIVASTIGMINE TARTRATE
- **Generic name:** RIVASTIGMINE TARTRATE
- **Active ingredients:** RIVASTIGMINE TARTRATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MACLEODS PHARMS LTD
- **Manufacturer:** Macleods Pharmaceuticals Limited
- **First approval:** 2014-08-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203148)
---
*AI Analytics · CC0 1.0*